News | July 14, 2025
Sun Pharma launches LEQSELVI in US for treatment of severe alopecia areata
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
The company received one observation in the Form-483
The company received 1 (One) observation in the Form-483
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
Enpatoran is a potential first-in-class oral therapy for CLE and SLE that is thought to selectively block the activation of Toll-like receptors (TLR)7 and TLR8
EBITDA for the period rose by 23.2% to Rs. 3,797 million
These observations are procedural in nature and none of them are related to data integrity
By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11
The company does not expect this development to have any material impact on the current business operations
Subscribe To Our Newsletter & Stay Updated
